The efficacy of tolvaptan for patients with chronic kidney disease and chronic heart failure
Not Applicable
Completed
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000031781
- Lead Sponsor
- ixon University School of Medicine Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine volume, body weight, blood pressure Physical assessment L/D (Na, K, Cl, osmolarity, BUN,Cr, ADH, urine electrolytes, L-FABP, NAG)
- Secondary Outcome Measures
Name Time Method